Terms: = Bone cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Diagnosis
35 results:
1. Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions.
Mei S; Alchahin AM; Tsea I; Kfoury Y; Hirz T; Jeffries NE; Zhao T; Xu Y; Zhang H; Sarkar H; Wu S; Subtelny AO; Johnsen JI; Zhang Y; Salari K; Wu CL; Randolph MA; Scadden DT; Dahl DM; Shin J; Kharchenko PV; Saylor PJ; Sykes DB; Baryawno N
Genome Med; 2024 Jan; 16(1):1. PubMed ID: 38281962
[TBL] [Abstract] [Full Text] [Related]
2. Role of non-coding RNAs as new therapeutic targets in regulating the emt and apoptosis in metastatic gastric and colorectal cancers.
Ebrahimi N; Hakimzadeh A; Bozorgmand F; Speed S; Manavi MS; Khorram R; Farahani K; Rezaei-Tazangi F; Mansouri A; Hamblin MR; Aref AR
Cell Cycle; 2023 Oct; 22(20):2302-2323. PubMed ID: 38009668
[TBL] [Abstract] [Full Text] [Related]
3. Machine learning based on SPECT/CT to differentiate bone metastasis and benign bone lesions in lung malignancy patients.
Wang H; Chen Y; Qiu J; Xie J; Lu W; Ma J; Jia M
Med Phys; 2024 Apr; 51(4):2578-2588. PubMed ID: 37966123
[TBL] [Abstract] [Full Text] [Related]
4. [Identification of epithelial-mesenchymal transition markers (emt) by immunohistochemistry in pediatric osteosarcoma and association with clinical outcomes].
Fonseca EV; Olaya N; Patifto EF; Aponte NH; Linares Ballesteros A
Andes Pediatr; 2022 Dec; 93(6):868-877. PubMed ID: 37906804
[TBL] [Abstract] [Full Text] [Related]
5. Long Noncoding RNA PCGEM1 Facilitates Tumor Growth and Metastasis of Osteosarcoma by Sponging miR-433-3p and Targeting OMA1.
Li J; Zhang Y; Sun F; Zhang G; Pan XA; Zhou Q
Orthop Surg; 2023 Apr; 15(4):1060-1071. PubMed ID: 36782343
[TBL] [Abstract] [Full Text] [Related]
6. Mechanisms, diagnosis and Treatment of bone Metastases.
Ban J; Fock V; Aryee DNT; Kovar H
Cells; 2021 Oct; 10(11):. PubMed ID: 34831167
[TBL] [Abstract] [Full Text] [Related]
7. Recent Advances in Pathology: the 2021 Annual Review Issue of The Journal of Pathology.
Herrington CS; Poulsom R; Koeppen H; Coates PJ
J Pathol; 2021 Jul; 254(4):303-306. PubMed ID: 34097314
[TBL] [Abstract] [Full Text] [Related]
8. LncRNA-TMPO-AS1 promotes apoptosis of osteosarcoma cells by targeting miR-329 and regulating E2F1.
Liu X; Wang H; Tao GL; Chu TB; Wang YX; Liu L
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11006-11015. PubMed ID: 33215415
[TBL] [Abstract] [Full Text] [Related]
9. Metastasizing basal cell carcinoma: A clinicopathologic and immunohistochemical study of 22 cases.
Mochel MC; Liaquat S; Moore JB; Hoang MP
J Cutan Pathol; 2021 Mar; 48(3):374-383. PubMed ID: 33010047
[TBL] [Abstract] [Full Text] [Related]
10. By targeting TRAF6, miR-140-3p inhibits TGF-β1-induced human osteosarcoma epithelial-to-mesenchymal transition, migration, and invasion.
Guo Q; Zhang N; Liu S; Pang Z; Chen Z
Biotechnol Lett; 2020 Nov; 42(11):2123-2133. PubMed ID: 32562135
[TBL] [Abstract] [Full Text] [Related]
11. Effect of CUL4A on the metastatic potential of lung adenocarcinoma to the bone.
Cao PP; Chen WJ; Pang HL; Shen WW; Xue P; Duan L; Xu YX; Liu LL; Zhang HL
Oncol Rep; 2020 Feb; 43(2):662-670. PubMed ID: 31894344
[TBL] [Abstract] [Full Text] [Related]
12. Integrated Therapeutic Targeting of the Prostate Tumor Microenvironment.
Livas L; Hasani S; Kyprianou N
Adv Exp Med Biol; 2020; 1296():183-198. PubMed ID: 34185293
[TBL] [Abstract] [Full Text] [Related]
13. Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma.
Wang JY; Yang Y; Ma Y; Wang F; Xue A; Zhu J; Yang H; Chen Q; Chen M; Ye L; Wu H; Zhang Q
Biomed Pharmacother; 2020 Jan; 121():109627. PubMed ID: 31810120
[TBL] [Abstract] [Full Text] [Related]
14. Biological and clinical relevance of metastasis-associated long noncoding RNAs in esophageal squamous cell carcinoma: A systematic review.
Talebi A; Masoodi M; Mirzaei A; Mehrad-Majd H; Azizpour M; Akbari A
J Cell Physiol; 2020 Feb; 235(2):848-868. PubMed ID: 31310341
[TBL] [Abstract] [Full Text] [Related]
15. MicroRNA-765 targets MTUS1 to promote the progression of osteosarcoma via mediating ERK/emt pathway.
Lv DB; Zhang JY; Gao K; Yu ZH; Sheng WC; Yang G; Gao YZ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4618-4628. PubMed ID: 31210288
[TBL] [Abstract] [Full Text] [Related]
16. Management of XLP-1 and itk deficiency: The challenges posed by PID with an unpredictable spectrum of disease manifestations.
Shadur B; Abuzaitoun O; NaserEddin A; Even-Or E; Zaidman I; Stepensky P
Clin Immunol; 2019 Jan; 198():39-45. PubMed ID: 30572125
[TBL] [Abstract] [Full Text] [Related]
17. New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.
Schiano C; Soricelli A; De Nigris F; Napoli C
Expert Rev Clin Immunol; 2019 Mar; 15(3):289-301. PubMed ID: 30570412
[TBL] [Abstract] [Full Text] [Related]
18. Identification of Differentially Expressed Genes Induced by Aberrant Methylation in Oral Squamous Cell Carcinomas Using Integrated Bioinformatic Analysis.
Zhang X; Feng H; Li D; Liu S; Amizuka N; Li M
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29875348
[TBL] [Abstract] [Full Text] [Related]
19. Decreased expression of ferritin light chain in osteosarcoma and its correlation with epithelial-mesenchymal transition.
Yu GH; Fu L; Chen J; Wei F; Shi WX
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2580-2587. PubMed ID: 29771443
[TBL] [Abstract] [Full Text] [Related]
20. MicroRNA-1277 Inhibits Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells by Targeting and Suppressing BMP4 Expression and Reflects the Significant Indicative Role in Hepatocellular Carcinoma Pathology and diagnosis After Magnetic Resonance Imaging Assessment.
Cao X; Xu L; Liu Q; Yang L; Li N; Li X
Oncol Res; 2019 Feb; 27(3):301-309. PubMed ID: 29562958
[TBL] [Abstract] [Full Text] [Related]
[Next]
